Never Miss a Potential Recovery Again

Sign up for Class
Action Alerts

Each year, class action lawsuits generate billions of dollars in settlement funds, but many shareholders fail to file a claim. Stay in the know regarding class action lawsuits by signing up for alerts.

Levi & Korsinsky, LLP does not share your information with others. There is no cost or obligation for you to submit. No spam will be sent to your email.

We Give Shareholders A Voice.

The market fluctuates, but we don’t. We give you straight answers from real attorneys who have spent decades helping shareholders protect their investments and recover their losses.

Settlements

$14 Million

Corcept Therapeutics Incorporated

$9.5 Million

Babcock & Wilcox Enterprises, Inc.

$40 Million

U.S. Steel

$7 Million

Aqua Metals, Inc.

$7.025 Million

WideOpenWest, Inc.

$8.25 Million

Helios and Matheson Analytics Inc.

$13.85 Million

Illumina, Inc.

$14.5 Million

Avon Products Inc.

I think you’ve done a superb job and I really appreciate the way this case was handled.

The Honorable Ronald B. Rubin in Teoh v. Ferrantino, C.A. No. 356627 (Cir. Ct. for Montgomery Cnty., MD 2012)

…a model for how [the] great legal profession should conduct itself.

Justice Timothy S. Driscoll in Grossman v. State Bancorp, Inc., Index No. 600469/2011 (N.Y. Sup. Ct. Nassau Cnty. Nov. 29, 2011)

I find the firm to be well-qualified to serve as Lead Counsel.

The Honorable Andrew L. Carter, Jr. In Snyder v. Baozun Inc., No. 1:19-CV-11290 (S.D.N.Y. Sept. 8, 2020)

In appointing the Firm Lead Counsel, the Honorable Analisa Torres noted our “extensive experience” in securities litigation.

White Pine Invs. v. CVR Ref., LP, No. 20 CIV. 2863 (S.D.N.Y. Jan. 5, 2021)

Class Counsel have demonstrated that they are skilled in this area of the law and therefore adequate to represent the Settlement Class as well.

Furthermore, with the increasing importance of compliance and risk management, kyc for law firms has become an essential component of legal services.

The Honorable Barry Ted Moskowitz in In re Regulus Therapeutics Inc. Sec. Litig., No. 3:17-CV-182-BTM-RBB (S.D. Cal. Oct. 30, 2020)

Who We Are

1
1
1
1
1
1

We're here for you

Find an Attorney

Required Field

Coin Image

Don't hesitate

Find a Case

Upcoming Deadlines

Investors interested in taking an active role in litigation have a limited time to petition the court for appointment as lead plaintiff. If you are interested in acting as a lead plaintiff, submit your transactions before the deadline, and our analysts will calculate your losses. Don't wait till the last minute- discuss your options today.
View All Deadlines

3

Days Left

INMD

InMode Ltd.

Deadline

April 15 2024

Class Period

6/4/21 - 10/12/23

Allegations

(i) InMode heavily discounts almost every device it sells; (ii) demand for InMode’s products was driven by InMode’s willingness to discount its products; (iii) InMode violated U.S. Food and Drug Administration (“FDA”) regulations by engaging in off-label marketing and promoting products for treatment of indications for which they lack FDA approval; and (iv) InMode violated FDA regulations by failing to timely report injuries caused by its devices.

Class Period

6/4/21 - 10/12/23

Deadline

April 15 2024

Learn More

3

Days Left

AMPL

Amplitude, Inc.

Deadline

April 15 2024

Class Period

9/21/21 - 2/16/22

Allegations

(a) Amplitude’s land-and-expand strategy was years away from significantly accelerating revenues among its newer client cohorts; (b) the rapid acceleration in the Company’s 2Q21 results resulted from the ephemeral effects of the COVID-19 pandemic which had not continued by the start of the class period, as Amplitude clients were expanding at a slower pace; and (c) as a result of (a)-(b) above, Amplitude’s business, operations, financial results, and prospects were materially worse than represented to investors during the class period.

Class Period

9/21/21 - 2/16/22

Deadline

April 15 2024

Learn More

4

Days Left

NOVA

Sunnova Energy International Inc.

Deadline

April 16 2024

Class Period

2/25/20 - 12/7/23

Allegations

(i) Sunnova routinely engaged in predatory business practices against disadvantaged homeowners and communities, the same groups that Project Hestia, a new solar loan channel, was purportedly intended to benefit; (ii) the foregoing conduct subjected the company to a heightened risk of regulatory and/or governmental scrutiny, as well as significant reputational and/or financial harm; and (iii) as a result, the Company’s public statements were materially false and misleading at all relevant times.

Class Period

2/25/20 - 12/7/23

Deadline

April 16 2024

Learn More

10

Days Left

INOD

Innodata Inc.

Deadline

April 22 2024

Class Period

5/9/19 - 2/14/24

Allegations

(1) Innodata did not have a viable AI technology; (2) its Goldengate AI platform, the centerpiece of Innodata’s reported AI technology, is a rudimentary software developed by just a handful of employees; (3) it was not going to utilize AI to any significant degree for new Silicon Valley contracts; (4) it was not effectively investing in research and development for AI; and (5) based on the foregoing, defendants lacked a reasonable basis for their positive statements about Innodata’s AI business and development and related financial results, growth, and prospects.

Class Period

5/9/19 - 2/14/24

Deadline

April 22 2024

Learn More

10

Days Left

DKS

DICK's Sporting Goods, Inc.

Deadline

April 22 2024

Class Period

5/25/22 - 8/21/23

Allegations

a) demand for products in Dicks Sporting Good’s outdoor segment was slowing faster than defendants represented, resulting in excess inventory; (b) the “structural changes” that defendants repeatedly touted, including differentiated products, improved pricing technology, and more efficient clearance channels, did not allow the Company to manage its excess inventory without hurting the Company’s profitability; (c) the need to liquidate excess inventory, including in the outdoor segment, would have a materially negative effect on the Company’s profitability; and (d) as a result of (a)-(c) above, defendants’ statements about the Company’s business condition and prospects were materially false and misleading when made.

Class Period

5/25/22 - 8/21/23

Deadline

April 22 2024

Learn More

10

Days Left

FOXF

Fox Factory Holding Corp.

Deadline

April 22 2024

Class Period

5/6/21 - 11/2/23

Allegations

According to the filed complaint, defendants made misleading statements and omissions regarding the Company’s business, financial condition, and prospects, particularly with regard to demand for Fox Factory’s products and inventory levels. Specifically, the complaint alleges that on November 2, 2023, after the markets closed, Fox Factory filed a Form 8-K with the SEC, reporting that its net sales for the third quarter of fiscal year 2023 decreased 19.1% year-over-year due to "higher levels of inventory across various channels." In addition, Fox Factory cut its full-year sales guidance from between $1.67B and $1.70B to between $1.45B and $1.47B, citing continued inventory destocking in its Specialty Sports Group segment. On this news, the price of Fox Factory's common stock declined $22.60, or 37.34%, to close at $60.53 per share on November 3, 2023.

Class Period

5/6/21 - 11/2/23

Deadline

April 22 2024

Learn More

11

Days Left

LTRX

Lantronix, Inc.

Deadline

April 23 2024

Class Period

5/11/23 - 2/8/24

Allegations

(i) Lantronix overstated demand and/or its visibility into demand for its IoT products, network-enabled devices, excluding traditional computers like laptops and servers; (ii) Lantronix’s customers were reducing elevated levels of inventory of IoT products, thereby causing a general slowdown in the Company’s business; (iii) certain of Lantronix’s embedded IoT revenues expected from a customer design win were delayed to the next fiscal year; (iv) as a result of all the foregoing, Lantronix anticipated lower sales for its embedded IoT solutions for fiscal year 2024; (v) accordingly, Lantronix was unlikely to meet its own previously issued guidance for fiscal year 2024; and (vi) as a result, the Company’s public statements were materially false and/or misleading at all relevant times.

Class Period

5/11/23 - 2/8/24

Deadline

April 23 2024

Learn More

14

Days Left

PANW

Palo Alto Networks Inc.

Deadline

April 26 2024

Class Period

8/18/23 - 2/20/24

Allegations

(1) the Company’s consolidation and platformization initiatives were not driving increased market share to a significant degree; (2) the Company would need to ramp up platformization and free product offerings to entice customers to adopt more of their platforms; (3) the Company’s high growth in billings was not sustainable; (4) new AI offerings were not facilitating greater platformization and consolidation; and (5) based on the foregoing, defendants lacked a reasonable basis for their positive statements about customer demand, billings, and platformization, as well as related financial results, growth, and prospects.

Class Period

8/18/23 - 2/20/24

Deadline

April 26 2024

Learn More

17

Days Left

KIND

Nextdoor Holdings, Inc. f/k/a Khosla Ventures Acquisition Co. II

Deadline

April 29 2024

Class Period

7/6/21 - 11/8/22

Allegations

(a) Nextdoor’s financial results prior to the November 2021 merger with Khosla Ventures Acquisition Co. II, had been temporarily inflated by the ephemeral effects of the COVID-19 pandemic, which had pulled forward demand for Nextdoor’s platform and cannibalized future advertising revenue growth; (b) rather than being sustained, such growth trends had already begun reversing at the start of the class period; (c) Nextdoor’s total addressable market was materially smaller than the 312 million households represented to investors; (d) by the start of the class period, Nextdoor’s most important market – the U.S. market – was already substantially saturated, impairing the Company’s ability to monetize users and increase its average revenue per weekly active user, or U.S. weekly active user metrics; (e) as a result of (a)-(d) above, Nextdoor’s revenue guidance for fiscal year 2022 had no reasonable basis in fact and the Company was tracking tens of millions of dollars below the revenue trajectory provided to investors.

Class Period

7/6/21 - 11/8/22

Deadline

April 29 2024

Learn More

17

Days Left

PLCE

The Children's Place, Inc.

Deadline

April 29 2024

Class Period

3/16/23 - 2/8/24

Allegations

(1) the Company was engaged in aggressive promotions; (2) as a result, the Company’s inventory values were overstated; (3) the foregoing was reasonably likely to have an adverse impact on fiscal 2023 financial results; and (4) as a result of the foregoing, defendants’ positive statements about the Company’s business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

Class Period

3/16/23 - 2/8/24

Deadline

April 29 2024

Learn More

17

Days Left

SNOW

Snowflake Inc.

Deadline

April 29 2024

Class Period

9/16/20 - 3/2/22

Allegations

(a) Snowflake had systematically oversold capacity to customers which created a misleading appearance of the demand for Snowflake’s products and services; (b) Snowflake had provided significant discounts to its customers prior to the Initial Public Offering (IPO) that temporarily boosted sales but would not be sustainable after the IPO and/or necessitate platform efficiency adjustments that negatively impacted client consumption and Snowflake’s revenue and profit margins; (c) as a result of (a)-(b) above, Snowflake’s customers were poised to roll over a material amount of unused credits (and thereby cannibalize future sales) at the end of their contracts’ terms or to refuse to renew their contracts at prior consumption levels or at all; (d) as a result (a)-(c) above, Snowflake’s product revenue and remaining performance obligations had been artificially inflated leading up to and during the class period; and (e) as a result of (a)-(d) above, defendants lacked a reasonable basis for their positive statements about Snowflake’s business, financials, and growth trajectory.

Class Period

9/16/20 - 3/2/22

Deadline

April 29 2024

Learn More

18

Days Left

VTYX

Ventyx Biosciences, Inc.

Deadline

April 30 2024

Class Period

10/21/21 - 11/6/23

Allegations

(i) VTX958, the Company's lead clinical product candidate, was less effective in treating psoriasis than defendants had led investors to believe; (ii) as a result, VTX958’s clinical and/or commercial prospects were overstated; (iii) accordingly, the Company had misrepresented its ability to develop and commercialize effective product candidates; (iv) Ventyx’s business prospects following the initial public offering were thus inflated; and (v) as a result, the Company’s public statements were materially false and misleading at all relevant times.

Class Period

10/21/21 - 11/6/23

Deadline

April 30 2024

Learn More

25

Days Left

IRBT

iRobot Corporation

Deadline

May 7 2024

Class Period

8/5/22 - 1/26/24

Allegations

(i) the August 2022 merger of the Company and Amazon, would place Amazon in a sufficiently dominant position in the market for robot vacuum cleaners that U.S. and European antitrust regulators were unlikely to approve the merger; (ii) iRobot had conducted inadequate due diligence into the merger and/or ignored significant risks weighing against the likelihood of regulatory approval; (iii) as a result of all the foregoing, iRobot overstated the likelihood for successfully completing the merger; and (iv) as a result, the Company’s public statements were materially false and misleading at all relevant times.

Class Period

8/5/22 - 1/26/24

Deadline

May 7 2024

Learn More

31

Days Left

AVXL

Anavex Life Sciences Corporation

Deadline

May 13 2024

Class Period

2/1/22 - 1/1/24

Allegations

The complaint alleges that on December 2, 2022, AVXL announced positive topline results from its Phase 2b/3 ANAVEX®2-73-AD-004 clinical trial of oral ANAVEX®2-73 (blarcamesine) for the treatment of mild cognitive impairment (MCI) due to Alzheimer’s disease (AD) and mild AD (collectively known as early AD). ANAVEX®2-73 met the primary endpoints ADAS-Cog1 and ADCS-ADL2 and key secondary endpoint CDR-SB3 with statistically significant results. An analyst questioned the Company’s claim noting “there are several key factors that point us to believe the data is provocative, but not yet compelling, given the choice of statistical analyses and other trial design/conduct ‘complexifiers’.” Additionally, a biotech journalist commented on AVXL’s findings stating “[w]hat sets Anavex apart from all the other biotechs on my radar screen is its habit of shifting the goalposts on clinical trials…Anavex announced “positive” outcomes from studies of its drug called blarcamesine — except the results were derived from efficacy endpoints that were not part of the original study designs.” Following this news, AVXL’s stock price fell by $2.47 per share, or approximately 20% to close at $9.58. Further on January 3, 2024, AVXL announced that results from its Phase 2/3 EXCELLENCE clinical trial for its candidate ANAVEX®2-73 in pediatric patients with Rett syndrome failed to show statistical significance towards its primary endpoints. Biotech analysts commented that “the negative study outcome was never in doubt…Anavex is a serial dissembler of clinical trial results.” Following this news, AVXL’s stock price fell by $3.26 per share, or approximately 35%.

Class Period

2/1/22 - 1/1/24

Deadline

May 13 2024

Learn More

32

Days Left

000

Next Bridge Hydrocarbons, Inc.

Deadline

May 14 2024

Class Period

This lawsuit is on behalf of all persons or entities that acquired shares of Next Bridge Hydrocarbons, Inc. in connection with the Company’s spin-off from Meta Materials, Inc. on or around December 14, 2022.

Allegations

The complaint alleges that NBH filed a registration statement in connection with its spin-off from Meta Materials that contained false and/or materially misleading statements. The statements at issue concern the value of the Company’s oil and gas assets and NBH’s transactions with related parties. The complaint alleges that these false and/or materially misleading statements violated the Securities Act of 1933 and, consequently, damaged shareholders who received NBH shares in conjunction with the spin-off.

Class Period

This lawsuit is on behalf of all persons or entities that acquired shares of Next Bridge Hydrocarbons, Inc. in connection with the Company’s spin-off from Meta Materials, Inc. on or around December 14, 2022.

Deadline

May 14 2024

Learn More

32

Days Left

INVZ

Innoviz Technologies Ltd.

Deadline

May 14 2024

Class Period

4/21/21 - 2/28/23

Allegations

(i) Innoviz had overstated the benefits that the Company was likely to derive from its purported contracts, partnerships, and/or collaborations with automotive companies; (ii) as a result, the Company was unlikely to achieve the level of profitability that defendants had represented to investors; (iii) accordingly, Innoviz had overstated its business and/or financial prospects; and (iv) as a result, the Company’s public statements were materially false and misleading at all relevant times.

Class Period

4/21/21 - 2/28/23

Deadline

May 14 2024

Learn More

32

Days Left

MMTLP

Next Bridge Hydrocarbons, Inc.

Deadline

May 14 2024

Class Period

This lawsuit is on behalf of all persons or entities that acquired shares of Next Bridge Hydrocarbons, Inc. in connection with the Company’s spin-off from Meta Materials, Inc. on or around December 14, 2022.

Allegations

The complaint alleges that NBH filed a registration statement in connection with its spin-off from Meta Materials that contained false and/or materially misleading statements. The statements at issue concern the value of the Company’s oil and gas assets and NBH’s transactions with related parties. The complaint alleges that these false and/or materially misleading statements violated the Securities Act of 1933 and, consequently, damaged shareholders who received NBH shares in conjunction with the spin-off.

Class Period

This lawsuit is on behalf of all persons or entities that acquired shares of Next Bridge Hydrocarbons, Inc. in connection with the Company’s spin-off from Meta Materials, Inc. on or around December 14, 2022.

Deadline

May 14 2024

Learn More

35

Days Left

SSRM

SSR Mining Inc.

Deadline

May 17 2024

Class Period

2/23/22 - 2/27/24

Allegations

(1) defendants materially overstated SSR Mining’s commitment to safety and the efficacy of its safety measures; (2) SSR Mining engaged in unsafe mining practices which were reasonably likely to result in a mining disaster; and (3) as a result, defendants’ statements about its business, operations, and prospects, were materially false and misleading and/or lacked a reasonable basis at all times

Class Period

2/23/22 - 2/27/24

Deadline

May 17 2024

Learn More

38

Days Left

CC

The Chemours Company

Deadline

May 20 2024

Class Period

2/10/23 - 2/28/24

Allegations

(1) certain of the Company’s senior executive officers manipulated Free Cash Flow targets as a means to maximize additional cash and stock incentive compensation applicable to executive officers pursuant to the Company’s annual incentive plans and long-term incentive plans; (2) the Company’s accounting practices and procedures, including its internal control over financial reporting, were deficient; and (3) as a result, defendants’ statements about the Company’s business, operations, and prospects lacked a reasonable basis.

Class Period

2/10/23 - 2/28/24

Deadline

May 20 2024

Learn More

38

Days Left

AGL

agilon health, inc.

Deadline

May 20 2024

Class Period

1/9/19 - 1/9/24

Allegations

(1) touting the Company’s purported visibility into utilization trends and medical costs; (2) failing to disclose increased medical costs that Agilon had incurred prior to and during the class period due to higher utilization of healthcare by MA patients; (3) falsely stating that its incurred-but-not-reported reserve was adequate; (4) making false and misleading statements about the effectiveness of its business model; (5) issuing overly optimistic financial guidance; and (6) issuing risk disclosures that were materially false and misleading because they characterized adverse facts that had already materialized as mere possibilities.

Class Period

1/9/19 - 1/9/24

Deadline

May 20 2024

Learn More

39

Days Left

SHLS

Shoals Technologies Group, Inc.

Deadline

May 21 2024

Class Period

5/17/22 - 11/7/23

Allegations

(1) Shoals did not deliver EBOS, electrical balance of system, products that met the highest levels of quality and reliability; (2) Shoals had received reports of exposed copper conduit in EBOS wire harnessess in a large number of solar fields and was aware that a significant portion of its wire harnesses had defects; (3) Shoals would have to incur between $60 million to $185 million in costs to remediate the wire shrinkback issue; and (4) Shoals had understated its cost of revenue by millions of dollars. As a result, defendants’ positive statements about the Company’s financial guidance, business, operations, and prospects were materially false and misleading and/or lacked a reasonable basis at all relevant times.

Class Period

5/17/22 - 11/7/23

Deadline

May 21 2024

Learn More

39

Days Left

PLUG

Plug Power Inc.

Deadline

May 21 2024

Class Period

5/9/23 - 1/16/24

Allegations

(i) Plug overstated its ability and/or efforts to mitigate the negative impacts that, among other things, supply chain constraints and material shortages could have or were having on the Company’s hydrogen business, as well as the sufficiency of its cash and capital to fund its operations; (ii) Plug continued to experience delays related to its green hydrogen production facility build-out plans, as well as in securing external funding sources to finance its growth plans; (iii) Plug downplayed the true scope and severity of all the foregoing when these issues were eventually revealed; (iv) as a result of all the foregoing, Plug also overstated the near-term prospects of its hydrogen production operations, as well as the viability of expanding those operations; and (v) as a result, the Company’s public statements were materially false and misleading at all relevant times.

Class Period

5/9/23 - 1/16/24

Deadline

May 21 2024

Learn More

42

Days Left

EVLV

Evolv Technologies Holdings, Inc.

Deadline

May 24 2024

Class Period

6/28/21 - 3/13/24

Allegations

(1) Evolv materially overstated the efficacy of its products; (2) the lack of effectiveness of Evolv’s products with regard to detecting knives and guns led to an increased risk of undetected weapons entering locations such as schools; (3) Evolv deceived the general public, its customers, and its investors regarding the effectiveness of its products; and (4) as a result, defendants’ statements about its business, operations, and prospects, were materially false and misleading and/or lacked a reasonable basis at all relevant times.

Class Period

6/28/21 - 3/13/24

Deadline

May 24 2024

Learn More

46

Days Left

BLUE

bluebird bio, Inc.

Deadline

May 28 2024

Class Period

4/24/23 - 12/8/23

Allegations

According to the complaint, on December 8, 2023, Blue announced that the Food and Drug Administration (FDA) approved its drug Lyfgenia (lovotibeglogene autotemcel), also known as lovo-cel for the treatment of sickle cell disease in patients ages 12 and older who have a history of vaso-occlusive events (VOEs). However, the Lyfgenia approval came with a black box warning for haematological malignancies after two patients developed AML during the clinical trials. Analysts noted that they did not expect the black box warning or the absence of a priority review voucher. Following this news, Blue’s stock price fell by $1.95 per share, or approximately 40% to close at $2.86 per share.

Class Period

4/24/23 - 12/8/23

Deadline

May 28 2024

Learn More

49

Days Left

LUNA

Luna Innovations Incorporated

Deadline

May 31 2024

Class Period

8/11/23 - 3/25/24

Allegations

(1) Luna Innovations financial statements from August 10, 2023 to the present included false figures as a result of improper revenue recognition; (2) as a result, Luna Innovations would need to restate its previously filed financial statements from August 10, 2023 to November 14, 2023; (3) Luna Innovations lacked adequate internal controls; and (4) as a result, defendants’ statements about its business, operations, and prospects, were materially false and misleading and/or lacked a reasonable basis at all times.

Class Period

8/11/23 - 3/25/24

Deadline

May 31 2024

Learn More

52

Days Left

HRT

HireRight Holdings Corporation

Deadline

June 3 2024

Class Period

10/28/21 - 11/30/-1

Allegations

(i) HireRight was exposed to customers with significant employment and hiring risk and the Company derived greater revenue growth from existing client hiring than from new client hiring; (ii) as a result, the Company’s revenue growth was unsustainable to the extent that it relied on the stability of its current customers’ hiring and/or the profitability of securing new customers; (iii) accordingly, HireRight had overstated its post- initial public offering business and/or prospects; and (iv) as a result, defendants’ statements about the Company’s business, operations, and prospects were materially false and misleading and/or lacked a reasonable basis at all relevant times.

Class Period

10/28/21 - 11/30/-1

Deadline

June 3 2024

Learn More

News

Stay informed with the latest in settlement notices, case updates, publications, analyst reports, and more.
View All News

Learn More

Litigation Report: Amplitude, Inc.
Case Introduction Fagan v. Amplitude, Inc., et al 3:24-cv-00898 On February 14, 2024, investors sued Amplitude, Inc. (“Amplitude” or the “Company”) in United States District Court, Northern District of California. Plaintiffs in the federal securities class action allege that they acquired Amplitude stock at artificially inflated prices between September 21, 2021 and February 16, 2022...Read more

April 11, 2024

Learn More

Fox Factory Holding Corp. Litigation Report
Case Introduction Marselis v. Fox Factory Holding Corp., et al 1:24-cv-00747-TWT On February 20, 2024, investors sued Fox Factory Holding Corp. (“Fox Factory” or the “Company”) in United States District Court for the Northern District of Georgia, Atlanta Division. Plaintiffs in the federal securities class action allege that they acquired Fox Factory stock at artificially...Read more

April 10, 2024

Learn More

Litigation Report: Ventyx Biosciences Inc.
Case Introduction Yuksel v. Ventyx Biosciences, Inc., et al 3:24-cv-00415-AGS-DDL On March 1, 2024, investors sued Ventyx Biosciences, Inc. (“Ventyx” or the “Company”) in United States District Court, Southern District of California. The federal securities class action alleges that plaintiffs acquired Ventyx stock pursuant and/or traceable to the Offering Documents (as defined in the complaint)...Read more

April 9, 2024

Our World-Class Team

Levi & Korsinsky’s attorneys are admitted in over 40 state, federal, and appeal courts across the country. We have the specialized securities skills to achieve outstanding results, and our impressive variety of backgrounds means that we can go up against large companies of any kind and win. Our powerhouse attorneys have backgrounds in accounting, engineering, SEC enforcement, mathematics, regulatory analysis, international business, and prosecution, to name just a few. . .

View Attorneys